Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otoacoustic emissions during sevoflurane versus desflurane anesthesia in healthy adults
ACTRN12614000758606Phase 4Completed
- Sponsor
- Gurcan Gungor
- Start
- Jun 2012
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane and desflurane (3 arms), sponsored by Gurcan Gungor. Primary endpoints: Overall transient evoked otoacoustic emissions and Distortion product otoacoustic emissions. Started Jun 2012; status: completed.
02
Drugs
sevofluranedesflurane
Beyond the preview
Go deeper on ACTRN12614000758606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000758606.